Fundraising FoxVyne Therapeutics
2 known investors
Find your way into Vyne Therapeutics
Sign up to see every warm intro you have to Vyne Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vyne Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vyne Therapeutics is a biopharmaceutical company developing treatments for Graves' disease and thyroid eye disease (TED). Its lead candidate is designed to block the interaction of autoantibodies with the TSH receptor to interrupt the disease mechanism.
Investors · 2
Frequently asked questions
- What does Vyne Therapeutics do?
- Vyne Therapeutics is a biopharmaceutical company developing treatments for Graves' disease and thyroid eye disease (TED). Its lead candidate is designed to block the interaction of autoantibodies with the TSH receptor to interrupt the disease mechanism.
- Who are Vyne Therapeutics's investors?
- Vyne Therapeutics's investors include F-Prime Capital, LifeSci Venture Partners.